Achieve Life Sciences, Inc. ACHV 深 沪
已收盘 05-15 16:00:00 美东时间
5.29
-0.500
-8.64%
华盛通- 最 高5.66
- 今 开5.60
- 成交量 129.47万股
- 最 低 5.28
- 昨 收 5.79
- 总市值 5.43亿
- 52周最高 6.15
- 市盈率 静 --
- 换手率 1.26%
- 52周最低 2.00
- 委 比 16.13%
- 总股本 1.03亿
- 历史最高 970.00
- 量 比 0.72
- 振 幅 6.56%
- 历史最低 1.84
- 每 手 1
- 风险率 0.94%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Achieve Life Sciences Reports Q1 2026 Results: Full Earnings Call Transcript
Achieve Life Sciences (NASDAQ:ACHV) held its first-quarter earnings conference ...
05-12 21:16
Earnings Scheduled For May 12, 2026
Companies Reporting Before The Bell • Sionna Therapeutics (NASDAQ:SION) is proj...
05-12 19:11
美股大行评级 | 瑞银大幅上调西部数据、希捷科技目标价！汇丰银行上调英特尔评级至"买入"，目标价从50美元升至95美元
今日重点评级关注：HC Wainwright & Co.：维持Century Therapeutics"买入"评级，目标价从2美元升至5美元；Oppenheimer：维持Climb Bio"跑赢大市"评级，目标价从10美元升至18美元
04-22 12:41
美股牛股 | Arxis上市首日涨超38%，公司为航空航天及国防电子元件制造商；量子计算概念股XNDU再涨近30%
Arxis上市首日涨超38%，公司为航空航天及国防电子元件制造商；量子计算概念股XNDU再涨近30%；医疗概念股CareDx涨超27%，剥离实验室产品业务以聚焦核心业务>>
04-17 19:07
Achieve Life Sciences Transfers Cystisinicline Manufacturing To Adare Pharma Solutions; Manufactures First Cytisinicline Engineering Batch At Adare
Adare Partnership Provides Supply Chain Redundancy and U.S.-based Manufacturing CapabilityCompany Reiterates Guidance - If Approved, Cytisinicline Commercial Launch Expected in First Half of 2027
04-15 20:04
美股大行评级 | 最高240美元，潜在涨幅53%！ARM获多家大行上调目标价；Braze 评级上演 “两极反转”，小摩、巴克莱上调，高盛、花旗下调
今日重点评级关注：HC Wainwright & Co.：维持OCUGEN"买入"评级，目标价从7美元升至10美元；HC Wainwright & Co.：维持Maze Therapeutics"买入"评级，目标价从60美元升至110美元
03-26 11:41
Achieve Life Sciences shares are trading lower after the company reported a Q4 EPS miss.
Achieve Life Sciences shares are trading lower after the company reported a Q4 ...
03-24 23:32
Achieve Life Sciences Q4 EPS $(0.28) Misses $(0.27) Estimate
Achieve Life Sciences (NASDAQ:ACHV) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.27) by 5.26 percent. This is a 22.22 percent increase over losses of $(0.36) per share
03-24 19:31
Earnings Scheduled For March 24, 2026
Companies Reporting Before The Bell • Fennec Pharmaceuticals (NASDAQ:FENC) is e...
03-24 19:11
Achieve Life Sciences Announces New Data On Cytisinicline As Smoking Cessation
Achieve also announces late-breaking survey data from ORCA-OL, demonstrating participant experience with extended cytisinicline use. These findings will be presented during the Society for Research on Nicotine &
03-04 21:07
